...
首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration.
【24h】

Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration.

机译:低渗肠胃外营养混合剂中钙和磷酸盐的相容性,用于外周静脉给药。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Precipitation of calcium (Ca) and phosphate (P) salts can lead to potentially lethal outcomes, especially in low-osmolarity parenteral nutrition (LO-PN) formulations. Three concentrations of amino acids (AA) and 2 concentrations of calcium gluconate and sodium phosphate injections on the compatibility of Ca and P in LO-PN admixtures were studied. METHODS: Final AA concentrations of 1%, 2%, or 3% (n = 3) and 5% glucose (G) were prepared with either 2.5 or 5 mmol/L (5 or 10 mEq) of Ca (n = 2) and 15 or 30 mmol/L of P (n = 2) for a total of 12 base (3 x 2 x 2) formulations. Triplicate bags of each were analyzed for subvisible micro-precipitates using the light obscuration (or extinction) method for particle counts per milliliter (PC) in the size range of 1.8-50 mum at 7 time intervals over 48 hours stored at 30 degrees C +/- 0.2 degrees C. Visual evaluation was performed using a high-intensity lamp against a black background for detection of macro-precipitates. The pH of all 36 admixtures was measured at 0 and 48 hours. Any precipitated material was isolated and characterized by polarized light microscopy and infrared spectroscopy. RESULTS: Of the 12 base LO-PN formulations tested, those containing 1% and 2% AA with 5 mmol/L of Ca and 30 mmol/L of P showed significant increases in PC, and some resulted in visible dibasic calcium phosphate precipitation. Analyses of variance based on concentrations of AA, Ca, P, and time were highly significant independent variables for increases in the PC of potentially embolic particles, that is, sizes >5 mum (P < .0001). The lowest concentrations of Ca and P, 2.5 and 15 mmol/L, respectively, had significantly lower PC (P < .05) for all sizes compared with the other Ca and P combinations. CONCLUSIONS: LO-PN admixtures (AA
机译:背景:钙(Ca)和磷酸盐(P)盐的沉淀可能导致潜在的致命后果,尤其是在低渗肠胃外营养(LO-PN)制剂中。研究了三种浓度的氨基酸(AA)和两种浓度的葡萄糖酸钙和磷酸钠注射液对LO-PN混合物中Ca和P相容性的影响。方法:使用2.5或5 mmol / L(5或10 mEq)的Ca(n = 2)制备最终AA浓度为1%,2%或3%(n = 3)和5%葡萄糖(G)。和15或30 mmol / L的P(n = 2),总共12种碱(3 x 2 x 2)制剂。使用光遮蔽(或消光)方法对每袋一式三份的袋中的亚微细微沉淀物进行分析,以在30℃+下储存48小时的7个时间间隔,对每毫升(PC)粒径范围为1.8-50 mum的颗粒计数+/- 0.2℃。使用高强度灯在黑色背景下进行视觉评估以检测宏观沉淀物。在0和48小时测量所有36种混合物的pH。分离出任何沉淀的材料,并通过偏振光显微镜和红外光谱进行表征。结果:在测试的12种碱性LO-PN配方中,含有1%和2%AA,5 mmol / L的Ca和30 mmol / L的P的PC含量显着增加,有些导致可见的磷酸氢钙沉淀。基于AA,Ca,P和时间浓度的方差分析是潜在栓塞颗粒PC的增加(即尺寸> 5微米(P <.0001))的高度重要的独立变量。与其他Ca和P组合相比,所有尺寸的Ca和P最低浓度分别为2.5和15 mmol / L,其PC值显着降低(P <.05)。结论:葡萄糖酸钙注射液中LO-PN混合物(AA

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号